Jerry Grisko
Analyst · CJS Securities. Please go ahead
Thank you, Brad. Before we move to Q&A, I want to provide further update on our progress with integration and our M&A strategy going forward. As we are wrapping up our traditional financial services busy season and most of the time sensitive client deadlines will soon be behind us, we now have the opportunity to accelerate our integration efforts, deepen collaboration and move forward with key initiatives and strategies that will begin to unlock the synergies and growth potential of our exciting combination with Marcum. A major area of focus in the months ahead will be the integration of our technology systems and moving our teams onto a unified technology environment. This is one of the most critical enablers to operational improvements, process standardization and our ability to drive consistency in everything from delivery of client services, to our team member experiences. Once in place, these integrated systems will allow us to streamline and automate processes, enhance data visibility and analysis, and ultimately deliver greater value to all of our stakeholders. As with every step in our integration process, we will continue to take a thoughtful and intentional approach, balancing progress with change management and training to support a smooth transition for our entire team. As we reflect on the past few months, I'm incredibly proud of the progress we've made on many fronts from identifying a group of incredibly talented leaders to drive our most impactful strategic initiatives to establishing new operating models. For our people, we continue to see high retention and strong engagement, and we're gathering feedback and input along the way. In terms of future M&A, with the successful completion of the Marcum transaction and our continued progress with integration, we're seeing an increased interest in CBIZ as an acquirer of choice. We expected this outcome and are thoughtfully evaluating a number of opportunities that will continue to build on our geographic presence in key markets and add strength to our existing service lines. Finally, I want to touch on two items that Brad touched on, I touched on in my opening remarks, specifically relating to organic revenue growth and our guidance for the year. As it relates to organic revenue growth, as you know, we've historically provided that guidance annually throughout the year. The reason that we were not able to do that this year is because when we look at the Marcum numbers, they were private, obviously, before they joined CBIZ. It's very difficult for us from an apples-to-apples comparison to have a good baseline for them, a good reliable baseline on their organic growth and -- so we just really don't have good line of sight. More importantly, we've already, as you would expect, and we expect, we've already begun to bring these businesses together. Regionally, we're combining their offices with ours. We have combined leadership or combining our teams. So while we do have a little bit of line of sight in the first quarter, that's going to be even more difficult as we progress throughout the year. With that said, we did have some line of sight in the first quarter, and I want to lend that to you. Based on the internal analysis that we have, very encouragingly as expected, the recurring portion of our accounting and tax business, both within legacy CBIZ and legacy Marcum performed as expected in that mid-single-digit range as well as our Benefits and Insurance group performing within that mid-single-digit rate. So I just want to convey that message that we're pleased with the performance of the business through the first quarter and where we expected it to be strong, it was strong, that being in our seasonally kind of predictable, more heavily more recurring business in the first quarter. I also want to touch on a couple of things. I noticed that there were some comments around our revenue not hitting guidance -- or I'm sorry, expectations, consensus for the year, that really falls into two buckets. As you know, we don't guide quarterly. We guide annually. So let me kind of bring a little bit of color to that. The two buckets are the known things. We knew some things that we couldn't convey to the analysts that created the consensus. And that resulted in about a $30 million change, and it's really pacing and timing on the year. But we had about $30 million in category. One being the SPAC business. We've talked a lot about this. Marcum within their capital markets practice traditionally did a lot of SPAC work. That work predictably has been winding down from a peak in 2023, and we saw it decline in '24 and expectedly decline again in '25. We're not concerned about that. We know that we'll sell over. There's other parts of the business that are in fact increasing, but we knew that SPAC business would wind down. The other thing that we expected, we've talked about this, we haven't quantified it is there were a couple of portions of the business that we were going to have conflicts with. Most notably, on their healthcare side, Marcum had a healthcare practice. That was in conflict with our government healthcare consulting practice. That's another piece of that. And then, of course, as you know, we announced last year, we sold our KA consulting business, that was in last year's number, isn't in this year's number. That's about impact on the quarter of about $30 million of known items. The unknown portion of it was really related to the economic climate. And I'll -- while there's a number of items there, I would just say it was the impact on the capital markets. So our SEC audit practice and the work that we would traditionally do there. When that -- when the markets just kind of hit the pause button as a result of some of the policies of the administration that work just kind of halted, no one saw that when we began the year. And of course, it had a like impact on our advisory practice. So those two things are about $20 million. So combined, about $50 million. Again, we don't guide the quarters. But when I saw the comments that we missed the consensus, I would say it wasn't far off. Our results weren't far off our internal expectations, certainly on the items that we knew and expected. Lastly, turning to guidance. We're really pleased, and again, the model affirms that despite some of the softness on the top line, we're able to yet affirm our earnings guidance for the year and other earnings-related metrics. From a top line, we don't want the message to be concerned over optimism or health of the business. That's why we didn't guide down on the top end of that. The guidance is really just a result of kind of a pragmatic look at what we've seen so far in the year and what we expect to see through the continuance of the year if conditions don't improve, again, with 23% of our revenue really being more advisory project discretionary side. We thought it was prudent at this point to widen that range on the revenue side because we know some things now that we didn't know when we gave that guidance. But in no term should it be viewed as a lack of optimism about the prospects for the range of the business. And in fact, we have some line of sight that if things improve a little bit, we will, in fact, hit that original guidance, but we wanted to broaden that range. So with that, I'll turn it over to Q&A.